HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert F Anderson Selected Research

azomycin

1/2019Engineering Escherichia coli NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy.
1/2018Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides.
4/2014Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers.
3/2012Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert F Anderson Research Topics

Disease

18Hypoxia (Hypoxemia)
01/2022 - 12/2002
17Neoplasms (Cancer)
01/2022 - 12/2003
2Tuberculosis (Tuberculoses)
01/2017 - 02/2009
1Hypersensitivity (Allergy)
10/2020
1Breast Neoplasms (Breast Cancer)
10/2020
1Acidosis
07/2019
1Inflammation (Inflammations)
01/2019
1Sarcoma (Soft Tissue Sarcoma)
12/2017
1Neglected Diseases
01/2017
1Drowning
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Atherosclerosis
03/2011
1Asthma (Bronchial Asthma)
03/2011
1Wounds and Injuries (Trauma)
12/2007
1Airway Obstruction (Choking)
12/2007
1Parkinson Disease (Parkinson's Disease)
10/2003

Drug/Important Bio-Agent (IBA)

16ProdrugsIBA
01/2022 - 12/2002
8Tirapazamine (SR 4233)IBA
01/2022 - 01/2003
7Pharmaceutical PreparationsIBA
01/2018 - 11/2003
5Cytotoxins (Cytolysins)IBA
01/2022 - 11/2008
5DNA (Deoxyribonucleic Acid)IBA
03/2012 - 10/2003
4azomycinIBA
01/2019 - 03/2012
3AcidsIBA
07/2019 - 03/2011
34-nitroimidazoleIBA
01/2019 - 04/2014
2Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 06/2004
2A-Form DNA (A-DNA)IBA
12/2021 - 12/2017
2Oxidoreductases (Dehydrogenase)IBA
10/2020 - 01/2006
2NitroreductasesIBA
01/2019 - 01/2016
2Phosphates (Orthophosphate)IBA
01/2018 - 01/2016
2NitroimidazolesIBA
01/2018 - 04/2014
2TH 302IBA
12/2017 - 03/2012
2TriazinesIBA
06/2014 - 11/2008
2Alkylating AgentsIBA
07/2010 - 11/2009
23-amino-1,2,4-benzotriazineIBA
03/2010 - 06/2005
2Free RadicalsIBA
06/2005 - 11/2003
1Hydroxyl RadicalIBA
10/2020
1CopperIBA
10/2020
1NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA
10/2020
1OxidesIBA
07/2019
1Phosphotransferases (Kinase)IBA
01/2019
1AmidesIBA
01/2019
1SN33623IBA
01/2019
1EnzymesIBA
01/2019
1EstersIBA
01/2019
1Topoisomerase II InhibitorsIBA
12/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2017
1Phosphorus (Red Phosphorus)IBA
01/2017
1ThiazolesIBA
01/2017
1Biological ProductsIBA
08/2016
1LigandsIBA
08/2016
1Coordination ComplexesIBA
08/2016
1SN34507IBA
01/2016
1SN35539IBA
01/2016
1PR-104IBA
01/2016
1CEN-209IBA
06/2014
1SulfonamidesIBA
04/2014
1isophosphamide mustard (IPAM)IBA
03/2012
1NucleotidesIBA
03/2012
1hypobromous acidIBA
03/2011
1Oxidants (Oxidizing Agents)IBA
03/2011
1NitrogenIBA
11/2008
1Oxygen (Dioxygen)IBA
11/2008
1Anesthetics (Anesthetic Agents)IBA
12/2007
1tretazicarIBA
06/2004
1Dopamine (Intropin)FDA LinkGeneric
10/2003
1AntioxidantsIBA
10/2003
1Uric Acid (Urate)IBA
10/2003
1Ammonium CompoundsIBA
12/2002
1AminesIBA
12/2002
1SaltsIBA
12/2002

Therapy/Procedure

4Therapeutics
07/2019 - 11/2009
2Radiotherapy
01/2022 - 01/2018
1Drug Therapy (Chemotherapy)
01/2022